Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer.

ABSTRACT: We performed a prospective study of circulating immune cell changes after stereotactic body radiotherapy (SBRT) in 50 early-stage NSCLC patients. We found no significant increase in CD8⁺ cytotoxic T lymphocytes at first follow-up (the primary endpoint) but detected a significant increase in expanding Ki-67⁺CD8⁺ and Ki-67⁺CD4⁺ T-cell fractions in patients treated with 10 Gy or less per fraction. SBRT can induce significant expansion in circulating effector T-cells immediately post-treatment.

SUBMITTER: Gkika E 

PROVIDER: S-EPMC9981559 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature